Journal
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY
Volume 115, Issue 6, Pages 477-480Publisher
WILEY
DOI: 10.1111/bcpt.12265
Keywords
-
Categories
Funding
- Social Development Fund of Zhenjiang, Jiangsu Province [SH2011036]
- Jiangsu Health International Exchange Program [JSH-2011-057]
Ask authors/readers for more resources
It has been shown that triptolide has beneficial effects in the treatment of neuropathic pain, but its effects on bone cancer pain (BCP) remain unclear. In this study, we aimed to explore the potential role of spinal regulated activation of normal T cell expressed and secreted (RANTES) in the antinociceptive effects of triptolide on BCP. A BCP model was induced by injecting Walker 256 mammary gland carcinoma cells into the intramedullary space of rat tibia. Intrathecal administration of triptolide (0.5, 1, 2g) could dose-dependently alleviate mechanical hyperalgesia and spontaneous pain. In addition, there were also concomitant decreases in RANTES mRNA and protein expression levels in spinal dorsal horn. These results suggest that the antinociceptive effects of triptolide are related with inhibition of spinal RANTES expression in BCP rats. The findings of this study may provide a promising drug for the treatment of BCP.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available